Study details
Enrolling now
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
University of Washington, the Collaborative Health Studies Coordinating Center
NCT IDNCT06654752ClinicalTrials.gov data as of Apr 2026
Target enrollment
430
Study length
about 4.2 years
Ages
3–18
Locations
31 sites in AL, AZ, CA +21
What this study is about
This trial is testing whether a streamlined approach to treating pulmonary exacerbations (PEx) in children with cystic fibrosis (CF) is safe and effective. It compares two different antibiotic treatment strategies for managing PEx, one using immediate oral antibiotics and the other only prescribing oral antibiotics if additional treatment is needed.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Immediate Oral Antibiotics
- 2.Tailored Treatment: Oral Antibiotics only if Additional Treatment needed
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Respiratory